Renal Impairment Kidney Disease Study

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

1

Condition

Kidney Failure (Pediatric)

Renal Failure

Kidney Failure

Treatment

N/A

Clinical Study ID

TX264162
  • Ages 18-85
  • All Genders

Study Summary

Single-dose Study to Evaluate subjects with Renal Impairment

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult males or females 18 to 85 of age, with mild to severe renal impairment

Exclusion

Exclusion Criteria:

Study Design

Study Start date:
January 26, 2021
Estimated Completion Date:

Study Description

A Phase 1, Open-label, Single-dose Study to Evaluate the Pharmacokinetics of XXX in Subjects With Renal Impairment

Connect with a study center

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.